99%+ Purity
COA Included
Sealed Vials
CJC-1295 (DAC)
Long-acting GHRH analog for sustained GH elevation
Long GH elevation
Key Benefits
- Extended growth hormone elevation for days
- Stimulates natural pituitary hormone production
- Innovative albumin-binding sustained-release technology
- May support consistent IGF-1 levels
- Less frequent dosing requirements
- Works through body's natural hormone pathways
- Research-grade peptide for serious investigators
Want to purchase this peptide?
Growth Hormone That Works for Days, Not Hours
Most GH protocols require daily injections and create hormone spikes that crash just as fast as they rise. CJC-1295 DAC changes the game completely—one injection delivers sustained growth hormone elevation for days, not hours. You get consistent anabolic signaling without the rollercoaster, which means better recovery, more stable energy, and results that actually compound over time.
Pituitary somatotroph / GHRH receptor pathway (sustained cAMP-mediated GH release)
About CJC-1295 (DAC)
CJC-1295 DAC is a long-acting growth hormone releasing hormone analog that binds to albumin in your bloodstream, extending its active life from minutes to days. Instead of directly injecting growth hormone, it stimulates your pituitary gland to produce and release more of its own GH through natural pathways. The result is sustained, consistent elevation of both growth hormone and IGF-1 levels with significantly less frequent dosing.
Who It's For
This is the peptide for serious practitioners who understand that consistency trumps intensity when it comes to growth hormone optimization. The extended-release mechanism makes it particularly valuable for those seeking steady anabolic support without the complexity of daily injection protocols. CJC-1295 DAC works best as a foundational element in long-term body composition and recovery strategies where sustained hormonal elevation provides cumulative benefits over months, not weeks.
Research Background
CJC-1295 DAC represents an innovative approach to growth hormone therapy that leverages the body's natural hormone regulation systems. Rather than directly injecting growth hormone, this peptide works by stimulating the pituitary gland to produce and release more of its own growth hormone through activation of specific receptors. The key innovation lies in its albumin-binding technology, which allows the peptide to remain active in the bloodstream for days rather than minutes.
Research has primarily focused on: 1) Understanding how the albumin-binding mechanism affects the duration and consistency of growth hormone elevation, 2) Investigating potential therapeutic applications for growth hormone deficiency states, and 3) Exploring the safety profile of sustained versus pulsatile GH stimulation. However, it's important to note that clinical research remains limited, with most published studies focusing on the underlying mechanisms rather than comprehensive human trials. The scientific community continues to investigate both the therapeutic potential and long-term safety considerations of this extended-release approach to growth hormone modulation.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 1 mg | |
Intermediate | 1 mg 2x/week | |
Advanced | 2mg 2x/week | |
Maximum | 1-3 mg 3x/week |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
5
24.0 mg needed ÷ 5 per vial
Total Investment
$300
$60.00 per vial
Per Dose
0.40 mL
40 units on U-100 syringe
Doses per Vial
5
5 ÷ 1.00 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Educational Resources
Featured in These Stacks
GH Axis Bundel
GH Axis Inventory
The GH Axis Inventory is the primary performance multiplier inside the peptide model. Growth hormone signaling influences body composition, tissue repair, recovery bandwidth, and metabolic responsiveness. Without this axis, fat loss becomes muscle loss, recovery slows, and training output plateaus. This inventory is intentionally layered to provide flexibility across intensity levels: Sermorelin serves as entry-level endogenous stimulation. Tesamorelin (10mg & 20mg) targets visceral fat and provides scalable leverage. Tesamorelin / Ipamorelin blends amplify GH pulses for structured recomposition. Tesamorelin / CJC / Ipamorelin creates triple-pathway synergy. CJC-1295 (DAC & No DAC) allows duration control — pulse vs sustained. Ipamorelin provides clean adjunct stimulation. IGF-1 LR3 delivers downstream growth expression. Fragment 176-191 targets fat mobilization pathways. This layered approach prevents over-reliance on a single compound and allows protocols to adapt to client progression. As volume increases, GH flexibility becomes revenue protection — because it prevents stagnation. Strategically, the GH axis: Enhances recomposition efficiency Preserves lean mass during fat loss Accelerates recovery Supports connective tissue repair Increases training capacity At scale, GH inventory becomes a central profit driver. It supports both base stacks and premium builds. It is not optional — it is structural. This is not a single product category. It is a signaling architecture built to scale results.
Includes
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
